Jefferson A. Evans

Array ( [id] => 1319387 [patent_doc_number] => 06605608 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-12 [patent_title] => 'Amino acid derivatives and drugs containing the same as the active ingredient' [patent_app_type] => B1 [patent_app_number] => 09/720433 [patent_app_country] => US [patent_app_date] => 2000-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33080 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1623 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/605/06605608.pdf [firstpage_image] =>[orig_patent_app_number] => 09720433 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1470186 [patent_doc_number] => 06407080 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-06-18 [patent_title] => 'N-(pyrimidinyl)-aspartic acid analogs as interleukin-1 converting enzyme inhibitors' [patent_app_type] => B2 [patent_app_number] => 09/740623 [patent_app_country] => US [patent_app_date] => 2000-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7500 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 387 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/407/06407080.pdf [firstpage_image] =>[orig_patent_app_number] => 09740623 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7640180 [patent_doc_number] => 06395735 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-05-28 [patent_title] => 'Pharmaceutical compounds' [patent_app_type] => B2 [patent_app_number] => 09/740380 [patent_app_country] => US [patent_app_date] => 2000-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14403 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/395/06395735.pdf [firstpage_image] =>[orig_patent_app_number] => 09740380 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1050154 [patent_doc_number] => 06861433 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-03-01 [patent_title] => 'Oxazolidinone photoaffinity probes' [patent_app_type] => utility [patent_app_number] => 09/738022 [patent_app_country] => US [patent_app_date] => 2000-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9595 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/861/06861433.pdf [firstpage_image] =>[orig_patent_app_number] => 09738022 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1490699 [patent_doc_number] => 06417188 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-09 [patent_title] => 'Arylalkanoylpyridazines' [patent_app_type] => B1 [patent_app_number] => 09/719467 [patent_app_country] => US [patent_app_date] => 2000-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6266 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 156 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/417/06417188.pdf [firstpage_image] =>[orig_patent_app_number] => 09719467 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1278745 [patent_doc_number] => 06645965 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-11 [patent_title] => 'Nitrate salts of antihypertensive medicines' [patent_app_type] => B1 [patent_app_number] => 09/719164 [patent_app_country] => US [patent_app_date] => 2000-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8755 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/645/06645965.pdf [firstpage_image] =>[orig_patent_app_number] => 09719164 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6509590 [patent_doc_number] => 20020025934 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-28 [patent_title] => 'Ethynyl alanine amino diol compounds for treatment of hypertension' [patent_app_type] => new [patent_app_number] => 09/729534 [patent_app_country] => US [patent_app_date] => 2000-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10817 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20020025934.pdf [firstpage_image] =>[orig_patent_app_number] => 09729534 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1278739 [patent_doc_number] => 06645964 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-11 [patent_title] => 'Chemical derivatives and their application as antitelomerase agent' [patent_app_type] => B1 [patent_app_number] => 09/722361 [patent_app_country] => US [patent_app_date] => 2000-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11162 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/645/06645964.pdf [firstpage_image] =>[orig_patent_app_number] => 09722361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1308543 [patent_doc_number] => 06617453 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-09 [patent_title] => 'Triphendioxazine compounds' [patent_app_type] => B1 [patent_app_number] => 09/718278 [patent_app_country] => US [patent_app_date] => 2000-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4726 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/617/06617453.pdf [firstpage_image] =>[orig_patent_app_number] => 09718278 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1515556 [patent_doc_number] => 06420561 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-16 [patent_title] => 'Amide compounds and use thereof' [patent_app_type] => B1 [patent_app_number] => 09/714435 [patent_app_country] => US [patent_app_date] => 2000-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36515 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 163 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/420/06420561.pdf [firstpage_image] =>[orig_patent_app_number] => 09714435 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1414627 [patent_doc_number] => 06525061 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-25 [patent_title] => 'Methods for the solid phase synthesis of 2-amino-4(H)-quinazolinone derivatives' [patent_app_type] => B1 [patent_app_number] => 09/711795 [patent_app_country] => US [patent_app_date] => 2000-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4374 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 276 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/525/06525061.pdf [firstpage_image] =>[orig_patent_app_number] => 09711795 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1589241 [patent_doc_number] => 06482802 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-19 [patent_title] => 'Use of neomycin for treating angiogenesis-related diseases' [patent_app_type] => B1 [patent_app_number] => 09/700436 [patent_app_country] => US [patent_app_date] => 2000-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 15052 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/482/06482802.pdf [firstpage_image] =>[orig_patent_app_number] => 09700436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1514915 [patent_doc_number] => 06420414 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-16 [patent_title] => 'Amino derivatives of EM-138 and methods of treating angiogenesis with same' [patent_app_type] => B1 [patent_app_number] => 09/710533 [patent_app_country] => US [patent_app_date] => 2000-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 6830 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/420/06420414.pdf [firstpage_image] =>[orig_patent_app_number] => 09710533 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1451439 [patent_doc_number] => 06455701 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-24 [patent_title] => 'Substituted diaryl or diheteroaryl methanes, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activity' [patent_app_type] => B1 [patent_app_number] => 09/708972 [patent_app_country] => US [patent_app_date] => 2000-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24770 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/455/06455701.pdf [firstpage_image] =>[orig_patent_app_number] => 09708972 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1303520 [patent_doc_number] => 06620796 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-16 [patent_title] => 'Combinatorial library synthesis and pharmaceutically active compounds produced thereby' [patent_app_type] => B1 [patent_app_number] => 09/709246 [patent_app_country] => US [patent_app_date] => 2000-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7950 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 306 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/620/06620796.pdf [firstpage_image] =>[orig_patent_app_number] => 09709246 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1467963 [patent_doc_number] => 06458955 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-01 [patent_title] => 'Process for preparation of pharmaceutically desired enantiomers' [patent_app_type] => B1 [patent_app_number] => 09/705304 [patent_app_country] => US [patent_app_date] => 2000-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2586 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/458/06458955.pdf [firstpage_image] =>[orig_patent_app_number] => 09705304 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1534071 [patent_doc_number] => 06410794 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-25 [patent_title] => 'Process for preparation of pharmaceutically desired chiral tetralone from tetralones' [patent_app_type] => B1 [patent_app_number] => 09/705306 [patent_app_country] => US [patent_app_date] => 2000-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2865 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 175 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/410/06410794.pdf [firstpage_image] =>[orig_patent_app_number] => 09705306 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1589928 [patent_doc_number] => 06482946 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-19 [patent_title] => 'High char yield benzoxazine compositions' [patent_app_type] => B1 [patent_app_number] => 09/705685 [patent_app_country] => US [patent_app_date] => 2000-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6963 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/482/06482946.pdf [firstpage_image] =>[orig_patent_app_number] => 09705685 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1451592 [patent_doc_number] => 06455736 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-24 [patent_title] => 'Process for preparation of pharmaceutically desired sertraline and sertraline analogs' [patent_app_type] => B1 [patent_app_number] => 09/705536 [patent_app_country] => US [patent_app_date] => 2000-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2299 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 268 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/455/06455736.pdf [firstpage_image] =>[orig_patent_app_number] => 09705536 [rel_patent_id] =>[rel_patent_doc_number] =>)